
    
      Primary Objective

      - effect of multiple different weekly and monthly doses of HM11260C and liraglutide (Victoza)
      as active control on gastric emptying

      Secondary Objectives

        -  evaluate the pharmacodynamic (PD) effects of multiple weekly and monthly doses of
           HM11260C and liraglutide after a Mixed Meal Tolerance Test

        -  evaluate the islet Î²-cell function after a graded glucose infusion (GGI) of different
           doses of HM11260C and liraglutide

        -  evaluate safety and tolerability of different doses of HM11260C and liraglutide

        -  evaluate the pharmacokinetic (PK) effect of multiple weekly and monthly doses of
           HM11260C
    
  